AR025391A1 - PROCEDURE FOR APPLYING A PREPARATION IN A LIQUID PHASE THAT CONTAINS AN ACTIVE PRINCIPLE ON A FLAT SUBSTRATE - Google Patents

PROCEDURE FOR APPLYING A PREPARATION IN A LIQUID PHASE THAT CONTAINS AN ACTIVE PRINCIPLE ON A FLAT SUBSTRATE

Info

Publication number
AR025391A1
AR025391A1 ARP000104415A AR025391A1 AR 025391 A1 AR025391 A1 AR 025391A1 AR P000104415 A ARP000104415 A AR P000104415A AR 025391 A1 AR025391 A1 AR 025391A1
Authority
AR
Argentina
Prior art keywords
applying
preparation
liquid phase
procedure
active principle
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of AR025391A1 publication Critical patent/AR025391A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Abstract

Un procedimiento para aplicar un preparado de principio activo sobre un sustrato, en particular sobre un sustrato con propiedades adhesivas, se caracterizapor aplicar el preparado en fase líquida, de manera análoga al procedimiento de impresion por chorro de tinta conocido por los expertos, sobre el sistematerapéutico plano con propiedades adhesivas, el cual, siendo de este modo portador de sustancias activas o auxiliares, ejerce un efecto sistémico al entrar encontacto íntimo con la piel humanao animal.A method for applying a preparation of active ingredient on a substrate, in particular on a substrate with adhesive properties, is characterized by applying the preparation in liquid phase, analogously to the inkjet printing process known to the experts, on the therapeutic system flat with adhesive properties, which, thus being a carrier of active or auxiliary substances, exerts a systemic effect upon entering intimate contact with human or animal skin.

ARP000104415 1999-08-25 2000-08-25 PROCEDURE FOR APPLYING A PREPARATION IN A LIQUID PHASE THAT CONTAINS AN ACTIVE PRINCIPLE ON A FLAT SUBSTRATE AR025391A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19940242A DE19940242A1 (en) 1999-08-25 1999-08-25 Applying a preparation in liquid phase containing active substances to a substrate constituting an adhesive therapeutic system involves use of a free jet similarly to bubble jet printing

Publications (1)

Publication Number Publication Date
AR025391A1 true AR025391A1 (en) 2002-11-27

Family

ID=7919505

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000104415 AR025391A1 (en) 1999-08-25 2000-08-25 PROCEDURE FOR APPLYING A PREPARATION IN A LIQUID PHASE THAT CONTAINS AN ACTIVE PRINCIPLE ON A FLAT SUBSTRATE

Country Status (2)

Country Link
AR (1) AR025391A1 (en)
DE (1) DE19940242A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10121471A1 (en) * 2001-05-02 2002-11-07 Beiersdorf Ag Plaster for controlled release of active agent to skin or wounds, comprising adsorbent, pressure-sensitive adhesive matrix surface-doped with active agent, e.g. dexpanthenol
US6723077B2 (en) 2001-09-28 2004-04-20 Hewlett-Packard Development Company, L.P. Cutaneous administration system
ATE471126T1 (en) 2002-11-07 2010-07-15 Abbott Lab PROSTHESIS WITH MULTIPLE, DISCRETE, UNMIXED DROPS OF MEDICATION
US8221495B2 (en) 2002-11-07 2012-07-17 Abbott Laboratories Integration of therapeutic agent into a bioerodible medical device
US8524148B2 (en) 2002-11-07 2013-09-03 Abbott Laboratories Method of integrating therapeutic agent into a bioerodible medical device
US8101244B2 (en) 2004-06-09 2012-01-24 Smithkline Beecham Corporation Apparatus and method for producing or processing a product or sample
TWI356036B (en) 2004-06-09 2012-01-11 Smithkline Beecham Corp Apparatus and method for pharmaceutical production
WO2011042913A1 (en) * 2009-10-07 2011-04-14 Venkata Surya Jagannath Yedida Transdermal therapeutic system
US8389041B2 (en) 2010-06-17 2013-03-05 Abbott Cardiovascular Systems, Inc. Systems and methods for rotating and coating an implantable device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531795A1 (en) * 1985-09-06 1987-03-12 Celamerck Gmbh & Co Kg MOTH PROTECTION AGENT AND METHOD FOR THE PRODUCTION THEREOF
DE4230589C1 (en) * 1992-09-12 1994-02-03 Lohmann Therapie Syst Lts Dosing process for volatile or thermolabile substances in liquid form for the production of i.a. flat pharmaceutical forms, in particular for the production of transdermal or dermal therapeutic systems
DE4242924A1 (en) * 1992-12-18 1993-12-09 Lohmann Therapie Syst Lts On=line prodn. of self-adhesive or non-adhesive prods. avoiding material waste - involves coating exactly defined areas on base with cover layer, using video camera to obtain application pattern for comparison with predetermined pattern, etc.
US5797898A (en) * 1996-07-02 1998-08-25 Massachusetts Institute Of Technology Microchip drug delivery devices

Also Published As

Publication number Publication date
DE19940242A1 (en) 2001-03-01

Similar Documents

Publication Publication Date Title
PE20000522A1 (en) PROTONIC DONOR ASSETS IN ABSORBENT ARTICLES
BR0114628A (en) Impact applicator microprojection retention member
WO2008038241A3 (en) Electrically activated gel array for transdermal drug delivery
HN2000000040A (en) INHIBITORS OF SORBITOL DEHYDROGENASE
ES2038718T3 (en) TRANSDERMAL THERAPEUTIC SYSTEM FOR THE APPLICATION OF ACTIVE PRODUCTS ON THE SKIN.
ES2137993T3 (en) THE USE OF GLYCERINE TO MODERATE THE TRANSDERMAL CONTRIBUTION OF MEDICINES.
EP1475080A3 (en) Cosmetic composition for the treatment of skin ageing and/or stressed skin
AR033423A1 (en) PHARMACEUTICAL SALTS CONSTITUTED OF AN ACTIVE PHARMACEUTICAL SUBSTANCE AND AT LEAST A SWEETENER, MEDICATIONS CONTAINING THESE SALTS AND USE OF THESE SALTS FOR THE PREPARATION OF MEDICINES
BRPI0517501A (en) medical device suitable for use in the administration of an active ingredient to or through the skin
NO900151D0 (en) DEVICE FOR DELIVERY OF MEDICINES WITH A FAVORABLE EFFECT
BRPI0307117B8 (en) anthranilic acid amides and their derivatives, as well as their uses as cosmetic and pharmaceutical active compounds
CY1108250T1 (en) INTERDERATIVE THERAPEUTIC SYSTEM FOR THE ADMINISTRATION OF NON-STEROID ANTIFLOGISTS WITH CARBOXYLAMIDES, AS ANY METHOD OF PRODUCTION
AR025426A1 (en) PHARMACEUTICAL SALTS OF THE ACTIVE SUBSTANCE TRAMADOL AND AT LEAST A SWEETENER, MEDICATIONS CONTAINING THESE SALTS, THE USE OF THESE SALTS FOR THE PREPARATION OF MEDICINES AND FORMS OF ADMINISTRATION CONTAINING THESE SALTS
CY1105138T1 (en) THEPMOU-TIGMATO-DTHS FOR ADMINISTRATION OF ROTIGOTINE
MX9203755A (en) IONTOPHORETICAL SUPPLY DEVICE FOR DRUGS OR THERAPEUTIC AGENTS, EQUIPPED WITH AN ADHESIVE OF ELECTRO-TRANSPORTATION.
TW570815B (en) Transdermal therapeutic system (TTS) containing the active substance fentanyl
ATE363900T1 (en) THERAPEUTIC PLASTER WITH CAPSAICIN CONTAINING POLYSILOXANE MATRIX
AR025391A1 (en) PROCEDURE FOR APPLYING A PREPARATION IN A LIQUID PHASE THAT CONTAINS AN ACTIVE PRINCIPLE ON A FLAT SUBSTRATE
AR019262A1 (en) PROCESS FOR THE PREPARATION OF A FORMULATION THAT INCLUDES AN ACTIVE SUBSTANCE OR ACTIVE SUBSTANCES ASSOCIATED WITH A CARRIER, AND PREPARATION FOR THIS PROCESS.
ES2172937T3 (en) 21-HYDROXI-6,19-OXIDOPROGESTERONE (21OH-6OP) AS A MEDICINAL PRODUCT TO TREAT THE EXCESS OF GLUCOCORTICOIDS.
AU6995700A (en) Therapeutic system containing an active substance for the application on the skin which contains at least two polymerous layers
AR021459A1 (en) PATCH CONTAINING ESTRADIOL FOR THE PERCUTANEOUS APPLICATION OF HORMONES.
AR026038A1 (en) TRANSDERMAL THERAPEUTIC SYSTEM FOR THE ADMINISTRATION OF ACETILSALICILIC ACID AND / OR SALICILIC ACID AND MANUFACTURING PROCESS
HUP9801130A2 (en) Transdermal therapeutic system for administering testosterone
AR028525A1 (en) TRANSDERMAL THERAPEUTIC SYSTEM FOR THE ADMINISTRATION OF LERISETRON